Stay updated on Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Sign up to get notified when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.

Latest updates to the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page
- Check3 days agoChange DetectedUpdates add 2026-03-12 and 2026-03-13 as new update timestamps and remove 2026-03-05 and 2026-03-06.SummaryDifference0.1%

- Check10 days agoChange DetectedNew release entries Revision: v3.4.3 added on 2026-03-06 and 2026-03-05, and older Revision: v3.4.2 entries dated 2026-02-27 and 2026-02-26 were removed.SummaryDifference0.1%

- Check17 days agoChange DetectedTwo recent update dates (2026-02-27 and 2026-02-26) were added to the study record history, and two earlier dates (2026-02-20 and 2026-02-19) were removed.SummaryDifference0.1%

- Check25 days agoChange DetectedNew study record dates were added (Feb 19, 2026 and Feb 20, 2026) and earlier dates (Feb 12, 2026 and Feb 13, 2026) were removed.SummaryDifference0.1%

- Check32 days agoChange DetectedRevision update: new entries dated 2026-02-12 and 2026-02-13 with Revision: v3.4.2, replacing the previous Revision: v3.4.1. These changes are administrative and do not affect core study details or eligibility.SummaryDifference0.1%

- Check39 days agoChange DetectedPage revision updated to v3.4.1 on 2026-02-06 (with related updates on 2026-02-05 and 2026-02), replacing v3.4.0. This appears to be an administrative/versioning update and does not modify core trial details, eligibility criteria, or outcomes.SummaryDifference0.1%

Stay in the know with updates to Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selumetinib with Vinblastine in Low-Grade Glioma Clinical Trial page.